2cureX appoints Kenneth Graabek Johansen, an experienced business and financial executive, as new CFO 28 January 2021
2cureX is pleased to announce that Kenneth Graabek Johansen has been appointed new CFO and will start... Read more
2cureX is pleased to announce that Kenneth Graabek Johansen has been appointed new CFO and will start... Read more
Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical... Read more
2cureX is pleased to announce that Fernando Andreu has been appointed new CEO and will start latest on... Read more
DANSK BIOTEK conducted its first virtual members’ meeting ever on December 11 on the topic ‘Covid-19... Read more
ARTIKEL Antallet af private kliniske forsøg i Danmark står stille Trods flere års offentlig-privat... Read more
IO Biotech today announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough... Read more
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) (the “Company” or “Y-mAbs”) a commercial-stage biopharmaceutical... Read more
Press Release LINK Medical has today announced the acquisition of IRW Consulting AB (IRW), a Nordic CRO... Read more